ETFs with exposure to ABIOMED, Inc. : November 24, 2017 Fri, 24 Nov 2017 15:20:02 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ABIOMED, Inc. Here are 5 ETFs with the largest exposure to ABMD-US. Comparing the performance and risk of ABIOMED, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
7 Tech Stocks to Buy That Sport Amazon-Like Growth Fri, 10 Nov 2017 17:51:37 +0000 There’s no doubt that we continue to be in a growth-fueled market. This hasn’t always been the case. In case you’ve forgotten, after the financial meltdown, it was dividend stocks that were the ‘new’ growth stocks. Everyone was scrambling for dividends, and not surprisingly, many stocks began to offer tantalizing dividends.
ABIOMED, Inc. :ABMD-US: Earnings Analysis: Q2, 2018 By the Numbers : November 8, 2017 Wed, 08 Nov 2017 19:27:52 +0000 Categories: Yahoo FinanceGet free summary analysis ABIOMED, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of ABIOMED, Inc. – Teleflex Incorporated, Boston Scientific Corporation and AtriCure, Inc. (TFX-US, BSX-US and ATRC-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 132.82 ... Read more
(Read more...)
Abiomed beats Street 2Q forecasts Thu, 26 Oct 2017 11:35:30 +0000 The Danvers, Massachusetts-based company said it had profit of 54 cents per share. Earnings, adjusted for non-recurring gains, were 44 cents per share. The results exceeded Wall Street expectations. The ...
See what the IHS Markit Score report has to say about Abiomed Inc. Tue, 17 Oct 2017 12:07:12 +0000 The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
See what the IHS Markit Score report has to say about ICU Medical Inc. Thu, 23 Nov 2017 13:07:03 +0000 The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
ICU Medical, Inc. – Value Analysis (NASDAQ:ICUI) : November 14, 2017 Tue, 14 Nov 2017 20:29:27 +0000 Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ICU Medical, Inc. a score of 63. Our analysis is based on comparing ICU Medical, Inc. with the following peers – Merit Medical Systems, Inc., Edwards Lifesciences Corporation, AngioDynamics, Inc., Insulet Corporation, Delcath Systems, Inc., Teleflex Incorporated, Becton, Dickinson and Company and Baxter International Inc. (MMSI-US, EW-US, ... Read more
(Read more...)
ICU Medical, Inc. breached its 50 day moving average in a Bullish Manner : ICUI-US : November 13, 2017 Mon, 13 Nov 2017 12:25:18 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ICU Medical, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
(Read more...)
ETFs with exposure to ICU Medical, Inc. : November 10, 2017 Fri, 10 Nov 2017 17:36:07 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ICU Medical, Inc. Here are 5 ETFs with the largest exposure to ICUI-US. Comparing the performance and risk of ICU Medical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
(Read more...)
ICU Medical posts 3Q profit Thu, 09 Nov 2017 23:27:52 +0000 The San Clemente, California-based company said it had profit of 1 cent per share. Earnings, adjusted for non-recurring costs and stock option expense, came to $1.12 per share. The medical device maker ...
ICU Medical, Inc. Announces Third Quarter 2017 Results Thu, 09 Nov 2017 21:05:00 +0000 SAN CLEMENTE, Calif., Nov. 09, 2017-- ICU Medical, Inc., a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced ...
ICU Medical, Inc. to Host Earnings Call Thu, 09 Nov 2017 17:00:00 +0000 NEW YORK, NY / ACCESSWIRE / November 9, 2017 / ICU Medical, Inc. (NASDAQ: ICUI ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 9, 2017 at 4:30 PM Eastern Time. ...
PerkinElmer to Present at Citi Global Healthcare Conference Tue, 21 Nov 2017 21:15:00 +0000 PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, today announced that the Company will present at the Citi Global Healthcare Conference on Wednesday, December 6, 2017 10:15 a.m.
ETFs with exposure to PerkinElmer, Inc. (United States) : November 6, 2017 Mon, 06 Nov 2017 17:20:25 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to PerkinElmer, Inc. (United States) Here are 5 ETFs with the largest exposure to PKI-US. Comparing the performance and risk of PerkinElmer, Inc. (United States) with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more
(Read more...)
PerkinElmer third quarter profit edges past Street forecast Thu, 02 Nov 2017 20:56:43 +0000 Laboratory equipment maker PerkinElmer Inc on Thursday reported slightly better-than-expected third-quarter profit and revenue and narrowed its full-year earnings forecast range while keeping the midpoint the same. PerkinElmer now expects adjusted 2017 earnings of $2.87 to $2.89 per share versus its prior view of $2.84 to $2.92. The company expects to close its $1.3 billion acquisition of German diagnostics company Euroimmun in the current quarter.
Orasure Technologies Inc: OraSure Technologies is a medical diagnostics company with a focus on point-of-care testing with products that use oral fluid samples and return accurate results in a matter of minutes. By streamlining the sample collection process and improving assay sensitivity, our products significantly improve the way diagnostic testing is conducted. The Company also markets a patented portable cryosurgical system for use by medical professionals in point-of-care settings.
OraSure Technologies, Inc.: Fading performance but may be making a comeback? Wed, 22 Nov 2017 16:58:59 +0000 Categories: Yahoo FinanceOraSure Technologies, Inc. relative valuation is NEUTRAL and it has a fundamental analysis score of 84. Our analysis is based on comparing OraSure Technologies, Inc. with the following peers – Trinity Biotech Plc Sponsored ADR Class A, Cooper Companies, Inc., Riot Blockchain Inc, Quidel Corporation, Response Genetics, Inc., Quest Diagnostics Incorporated, ERBA Diagnostics, Inc., Chembio ... Read more
(Read more...)
Today’s Research Reports on Stocks to Watch: Medtronic and Orasure Technologies Wed, 22 Nov 2017 13:10:00 +0000 NEW YORK, NY / ACCESSWIRE / November 22, 2017 / Shares of Medtronic closed up nearly 5% after beating in both the top and bottom line in its second quarter earnings report. Shares of OraSure technologies ...
ETFs with exposure to OraSure Technologies, Inc. : October 20, 2017 Fri, 20 Oct 2017 14:21:35 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OraSure Technologies, Inc. Here are 5 ETFs with the largest exposure to OSUR-US. Comparing the performance and risk of OraSure Technologies, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
(Read more...)
OraSure Technologies, Inc. – Value Analysis (NASDAQ:OSUR) : October 18, 2017 Wed, 18 Oct 2017 14:16:31 +0000 Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives OraSure Technologies, Inc. a score of 84. Our analysis is based on comparing OraSure Technologies, Inc. with the following peers – Trinity Biotech Plc Sponsored ADR Class A, Cooper Companies, Inc., BiOptix, Inc., Quidel Corporation, Response Genetics, Inc., Quest Diagnostics Incorporated, ERBA Diagnostics, Inc., Chembio Diagnostics, Inc., ... Read more
(Read more...)
OraSure Technologies, Inc. breached its 50 day moving average in a Bearish Manner : OSUR-US : October 17, 2017 Tue, 17 Oct 2017 12:16:00 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for OraSure Technologies, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
(Read more...)
OraSure Technologies Earnings Conference Call Invitation Wed, 11 Oct 2017 10:00:00 +0000 BETHLEHEM, Pa., Oct. 11, 2017-- OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2017 third quarter financial results, 2017 fourth quarter financial guidance and certain ...
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Accum/Dist: 1.46 (median winner: 1.53)
GSA Rank: 80.07 (winner: 75.66)
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.